Background In 2017, the prevalence of obesity (BMI≥= 30 kg/m2) in Germany was
approximately 16%. Obesity increases an individual's risk of developing type 2 diabetes …

Abstract The International Federation for the Surgery of Obesity and Metabolic Disorders
(IFSO) issued a position statement on the role of one anastomosis gastric bypass (OAGB) in …

Objective This study aimed to determine which bariatric procedure allows patients to obtain
the best weight‐loss outcomes and a remission of type 2 diabetes. Methods Databases were …

Das Fortschreiten einer NASH ist assoziiert mit Leberzellstress, konsekutiver Entzündung
und Fibrose, mit potentieller Entwicklung einer Leberzirrhose, portaler Hypertension und der …

Background One-anastomosis gastric bypass (OAGB-MGB) is currently the third performed
primary bariatric surgical procedure worldwide. However, the procedure is hampered by …

Purpose One anastomosis/mini gastric bypass (OAGB/MGB) is up to date the third most
performed obesity and metabolic procedure worldwide, which recently has been endorsed …

Background There is a paucity of data comparing 30-day morbidity and mortality of sleeve
gastrectomy (SG), Roux-en-Y gastric bypass (RYGB), and one anastomosis gastric bypass …

Obesity and the corresponding burden of related diseases is a major public health issue
worldwide that is reaching pandemic proportions. Bariatric surgery is the only intervention …

A network meta‐analysis of randomized controlled trials (RCTs) was performed to determine
the hierarchies of different bariatric surgeries in patients with obesity and type 2 diabetes …

The prevalence of obesity continues to rise around the world, driving up the need for
effective and durable treatments. The field of metabolic/bariatric surgery has grown rapidly in …